Severity
Moderate
CPSC recall · Reported March 7, 2018
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving ointment contains lidocaine, posing a risk of poisoning to young childr…
First Aid Research Corp., of Jupiter, Fla. recalled This recall involves Maximum Strength Bacitraycin Plus Ointment with Lidocaine. The recal… — a moderate-severity action.
First Aid Research Recalls Maximum Strength Bacitraycin Plus Ointment With Lidocaine Due … was recalled by First Aid Research Corp., of Jupiter, Fla. in March 7, 2018. Reason: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving o…. Remedy: Consumers should immediately place the recalled ointment out of the reach of children and…. Verify recall #18118 with the CPSC before acting.
The recall
First Aid Research Corp., of Jupiter, Fla. issued this moderate-severity CPSC recall — The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving o….
Sourced from official CPSC enforcement records. Verify recall #18118 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This CPSC action (record #18118) was formally reported on March 7, 2018. It is classified under Moderate severity, with a current status of Active. First Aid Research Corp., of Jupiter, Fla. is listed as the recalling firm. Federal records list the affected scope as About 500,000.
The documented reason for this recall is: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving ointment contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or inges… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately place the recalled ointment out of the reach of children and contact United Exchange, the product's importer, for instructions on how to receive a full refund from the pl… — consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category — 3,146 children & baby products recalls on record
Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger — we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
About 500,000
Related Recalls
6
0 from same agency
This recall involves Maximum Strength Bacitraycin Plus Ointment with Lidocaine. The recalled ointment is in a white, one ounce tube with "Bacitraycin Plus" printed on the front in green. Lidocaine is one of the two active ingredients listed on the back of the tube. The tube measures approximately 5 inches long by 1 inch wide. The lot number is printed on the end of the tube. The following lot numbers are included in the recall: Lot Numbers 16001 through 16002 404001 through 404002 405001 through 405003 406001 through 406004 407001 through 407002 415001 through 415010 416001 through 416003 417001 through 417004
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving ointment contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Consumers should immediately place the recalled ointment out of the reach of children and contact United Exchange, the product's importer, for instructions on how to receive a full refund from the place of purchase.
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Moderate |
| Status | Active |
| Recall number | 18118 |
| Date reported | March 7, 2018 |
| Date initiated | March 7, 2018 |
| Recalling firm | First Aid Research Corp., of Jupiter, Fla. |
| Affected scope | About 500,000 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately place the recalled ointment out of the reach of children and contact United Exchange, the product's …
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Keep tracking product safety across the federal recall archive.
Recall Checker
Search the full archive by product name, brand, or recall number across every agency.
Check a product →
CPSC recalls
Every recall issued by CPSC, newest first.
Browse the feed →
RecallRadar
Live feed of the latest recalls across the FDA, CPSC and NHTSA — filter by agency and severity.
View the live feed →
Rankings
The largest recalls by units affected and the most-recalled product categories.
See the rankings →
Browse by category
Find recalls by product type to spot recurring defect patterns.
All categories →
What to do next
A step-by-step guide to refunds, repairs, and returns after a recall.
Read the guide →
Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.
Wawa Beverage Company · 2026-06-03
Wawa Beverage Company · 2026-06-03
Wawa Beverage Company · 2026-06-03
Wellnov Supplements LLC · 2026-05-27
Wellnov Supplements LLC · 2026-05-27
Compare this recall with Wawa Diet Iced Tea Lemon Pint (16oz),Plastic bottle →
Source: FDA, CPSC, and NHTSA federal recall databases. This recall: CPSC, reported March 7, 2018.
Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.